ASCO Annual Meeting

First-in-Class Drug Preserves Blood Counts During Chemotherapy for Lung Cancer

July 23rd 2019, 7:00pm

Article

Given with each dose of chemotherapy, trilaciclib temporarily puts bone marrow to sleep, helping to prevent fevers, infections and hospital stays in patients with small cell lung cancer.

Ongoing Study Will Examine Cardiac Toxicity of Breast Cancer Treatment

July 23rd 2019, 12:00am

Article

Patients with breast cancer can still enroll in a clinical trial that is seeking to find the cause behind cardiac toxicity related to anthracycline-based treatment.

The Patient Voice Matters in Cancer Care

July 19th 2019, 5:00pm

Article

Researchers examined what goes into treatment decision-making for patients with multiple myeloma.

With Addition of Checkpoint Inhibitors, Chemotherapy 'Not Going Away Anytime Soon'

July 17th 2019, 8:32pm

Video

With new ways to treat chemotherapy-induced side effects, it seems that chemotherapy, combined with checkpoint inhibitors, is here to stay for the foreseeable future, according to one expert.

Combinations May Be the Future of Liver Cancer Treatment

July 15th 2019, 10:05pm

Article

With a wealth of drugs available for the treatment of liver cancer, one expert explained how combination therapy may be where the future is headed.

A Trial for Every Patient and a Patient for Every Trial

July 15th 2019, 6:42pm

Video

One expert weighs the benefits and drawbacks of expanding clinical trials to be more inclusive and reflective of the general patient population with cancer.

What Patients Should Know About Genetic Testing and Hereditary Cancer Risk

July 15th 2019, 5:20pm

Article

A breast cancer survivor and hereditary cancer expert discussed how patients can find accurate information about genetic mutations.

Practice-Changing Treatments for Bladder Cancer

July 10th 2019, 9:17pm

Article

A medical oncologist discusses the findings of three clinical trials presented during the 2019 American Society of Clinical Oncology Annual Meeting.

Future of Renal Cell Carcinoma: Hope Is on the Horizon

July 10th 2019, 6:05pm

Article

One expert discusses the “extremely interesting and extremely dynamic” field of renal cell carcinoma, and how recent research and FDA actions could offer hope for patients and their doctors.

Limited Cancer-Related Fatigue Regression Highlights Need for Intervention

July 9th 2019, 5:00pm

Article

While half of women with gynecologic cancer reported experiencing significant fatigue during treatment, only 8% of survivors had symptoms regress without intervention.